John L. Marshall, MD: Zolbetuximab is a drug that you probably don’t know the name of, but you’re going to soon. Though you may have heard of claudin 18.2. Now, that’s been in the literature for a ...
A study conducted by digestive healthcare company Oshi Health in partnership with a national health plan found that virtual multidisciplinary care for gastrointestinal disorders improves patient ...
Comparing outcomes for early and late drainage of malignant ascites. Background: Black individuals, including African Americans, experience a disproportionate cancer burden and exhibit the lowest ...
A new study shows that even use of low-dose aspirin increases the risk of gastrointestinal bleeding, which is increased further with use of cardiovascular disease-preventing therapies, such as ...
Among the most recently approved drugs for weight management, glucagon-like peptide 1 (GLP-1) agonists have garnered considerable attention; however, the effects of these drugs on the gastrointestinal ...
In a recent study published in The Journal of Nutrition, a group of researchers estimated dietary polyphenol intake in healthy adults and investigated its associations with gastrointestinal (GI) and ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic neuroendocrine ...
71.4% of MetaXplore™ reports from 4,616 patients identified actionable results 41.9% tested positive for abnormal microbiome markers linked to gastrointestinal health 9.9% tested positive for ...
Researchers from the University of Miami’s Miller School of Medicine have published the results of a new study that could help develop better treatment strategies bacterial gastrointestinal infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results